![Christopher J. Barden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Christopher J.
Barden is the founder of DeNovaMed, Inc. and holds the title of Director.
DeNovaMed, Inc. was founded in 2006.
Dr. Barden is the founder of Treventis Corp.
and holds the title of Chief Executive Officer.
Aktive Positionen von Christopher J. Barden
| Unternehmen | Position | Beginn |
|---|---|---|
Treventis Corp.
 Treventis Corp. BiotechnologyHealth Technology Develops a small molecule drugs for Alzheimer’s and other protein misfolding diseases | Vorstandsvorsitzender | - |
DeNovaMed, Inc.
 DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology Develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs | Gründer | 01.01.2006 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Treventis Corp.
Treventis Corp. BiotechnologyHealth Technology Develops a small molecule drugs for Alzheimer’s and other protein misfolding diseases | Health Technology |
DeNovaMed, Inc.
DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology Develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs | Health Technology |
